AGLE News and Press, Aeglea BioTherapeutics Inc.

2023-11-27 08:59:20 ET More on Aeglea BioTherapeutics Aeglea BioTherapeutics announces 1-for-25 reverse stock split Aeglea BioTherapeutics appoints Burrows as CFO, King-Jones as CLO Seeking Alpha’s Quant Rating on Aeglea BioTherapeutics For further det...

Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD PR Newswire Company will begin trading on Nasdaq under trading sy...

2023-11-20 05:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-09 17:42:45 ET More on Aeglea BioTherapeutics Aeglea BioTherapeutics announces 1-for-25 reverse stock split Aeglea BioTherapeutics appoints Burrows as CFO, King-Jones as CLO Seeking Alpha’s Quant Rating on Aeglea BioTherapeutics Historical earn...

Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Continued progress across the Company's potentially best-in-class inflammatory bowel disease (IBD) portfolio SPY001, a half-life extended anti-α4β...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Aeglea BioTherapeutics Inc. (AGLE) is expected to report $-0.44 for Q3 2023

Aeglea BioTherapeutics to Participate in Upcoming November Investor Conferences PR Newswire WALTHAM, Mass. , Oct. 30, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutic...

Aeglea BioTherapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass. , Oct. 2, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential...